Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.

NCT ID: NCT02567149


Title
Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.
Purpose
The primary objective is to determine whether intralesional cidofovir is effective at bringing about the total or near-total resolution of warts that have already proven recalcitrant to standard therapy. The secondary objective is to determine the tolerability of this new mode of administration of cidofovir in the pediatric population
Details
This study includes pediatric patients with history of either primary or iatrogenic immune-suppression who are seeking treatment of warts that have already proven recalcitrant to standard therapy. The first cohort will include 4 patients ages 12 to 17. After all tests indicate treatment safety, the second cohort will be recruited and will include patients ages 8 to 17.
Conditions
Warts
Keywords
Wart
Source
University of Minnesota - Clinical and Translational Science Institute
Sponsors
University of Minnesota - Clinical and Translational Science Institute
Status
Not yet recruiting
Acronym
Last Updated
09 May 2016
URL
Official Link
Locations
United States